Turicibacter

A Gram-positive, facultatively anaerobic genus within the class Erysipelotrichia (phylum Firmicutes) that has become one of the most frequently identified taxa in gut-brain and gut-immune Mendelian randomization studies. Turicibacter sanguinis, the type species, possesses a remarkable property: it directly interacts with the host serotonin transporter (SERT), making it one of the few bacteria known to modulate host serotonin biology at the molecular level. This serotonin connection, combined with MR evidence linking Turicibacter to Hashimoto's thyroiditis, coronary heart disease, and ASD, positions it as a multi-system immunomodulatory taxon.

Taxonomy

• Turicibacter sanguinis — the type species; originally isolated from blood cultures, hence the species name.
• Family Turicibacteraceae, order Erysipelotrichales, class Erysipelotrichia, phylum Firmicutes.
• The genus is distantly related to the core Clostridia despite being within Firmicutes; Erysipelotrichia represents a distinct evolutionary lineage.

Metal Dependencies

Iron:

• Turicibacter has modest iron requirements typical of low-GC Firmicutes.
• Iron-dependent oxidoreductases support its facultative metabolism.
• The genus name sanguinis (from blood) reflects its original isolation site, not an iron-piracy strategy, though its ability to survive in blood suggests adaptation to iron-rich environments.

Key Features

Serotonin Transporter Interaction

Turicibacter is one of the few gut bacteria demonstrated to directly interact with the host serotonin transporter (SERT/SLC6A4). This interaction:

• Allows Turicibacter to sense and respond to host serotonin levels
• Influences local serotonin availability in the gut, affecting motility, secretion, and immune signaling
• Creates a bidirectional communication channel between host serotonin biology and microbial ecology
• Connects to the broader serotonin regulation pathway where clostridia stimulate EC cell serotonin production

Bile Acid Metabolism

Turicibacter participates in bile acid modification, contributing to the conversion of primary to secondary bile acids in the gut. This function links it to hepatic metabolism and cholesterol homeostasis.

Ecological Role

In the Healthy Gut

Turicibacter is a low-to-moderate abundance member of the gut microbiota. Its serotonin-sensing capability allows it to occupy a niche at the host-microbe interface, responding to intestinal serotonin gradients that vary with meal intake, stress, and circadian rhythms.

Dietary Responsiveness

Turicibacter shows dramatic dietary responsiveness:

• Ketogenic diet: 120-fold increase in abundance in mice ma 2018 ketogenic diet neurovascular function gut microbiome mice, among the most extreme dietary expansions reported for any gut taxon
• This extreme responsiveness suggests Turicibacter thrives on the metabolic byproducts of ketosis (ketone bodies, altered bile acid composition) rather than dietary fiber

Conditions Associated

Hashimoto's Thyroiditis (Causal Risk Factor)

Turicibacter is causally associated with increased HT risk (OR = 1.16, p = 0.020) pei 2024 immune cells gut microbiota hashimotos mendelian, alongside intestinimonas (OR 1.20). The serotonin-modulating capability of Turicibacter may be relevant: serotonin influences thyroid hormone synthesis and immune regulation in the thyroid gland.

Coronary Heart Disease (Risk Factor)

Turicibacter increases CHD risk (OR = 1.12) via MR hu 2024 gut microbiota chd mendelian randomization. The bile acid metabolism function may link Turicibacter to cholesterol homeostasis and cardiovascular risk.

Autism Spectrum Disorder

The picture is complex:

• MR suggests a possible positive association with ASD (OR = 1.14, borderline significance) li 2023 gut microbiota asd bidirectional mr
• A systematic review found Turicibacter consistently decreased in ASD alongside Bifidobacterium, Blautia, Dialister, Prevotella, and Veillonella liu 2019 altered microbiota composition asd systematic review
• The discrepancy may reflect the difference between causal (MR) and observational findings, or treatment effects in observational cohorts

Multiple Sclerosis / EAE

Turicibacter is positively correlated with experimental autoimmune encephalomyelitis (EAE) severity in mice libbey 2018 diet microbiota eae, consistent with a pro-inflammatory role in autoimmune neuroinflammation. Anti-CD20 B-cell depletion therapy in MS reverses the dysbiosis pattern including Turicibacter abundance.

Atrial Fibrillation (Protective)

Paradoxically, Turicibacter is protective against atrial fibrillation (OR = 0.904) dai 2024 bidirectional mr gut microbiota cvd, showing that cardiovascular effects are outcome-specific.

Key Studies

• pei 2024 immune cells gut microbiota hashimotos mendelian (MR) — HT risk factor (OR 1.16).
• hu 2024 gut microbiota chd mendelian randomization (MR) — CHD risk factor (OR 1.12).
• li 2023 gut microbiota asd bidirectional mr (MR) — Possible ASD association (OR 1.14).
• ma 2018 ketogenic diet neurovascular function gut microbiome mice (animal model) — 120-fold ketogenic diet expansion.
• libbey 2018 diet microbiota eae (animal model) — EAE severity correlation.

Cross-References

• hashimotos thyroiditis — causal risk factor via MR
• intestinimonas — co-identified as HT risk taxon
• serotonin — Turicibacter interacts with host serotonin transporter
• clostridia — spore-forming Clostridia regulate EC cell serotonin, linking to Turicibacter's serotonin niche
• coronary-heart-disease — CHD risk factor via MR
• autism spectrum disorder — complex association (MR risk vs. observational depletion)
• bile acid metabolism — Turicibacter participates in bile acid modification